Skip Navigation



Glycobiology Advance Access published online on March 17, 2009

Glycobiology, doi:10.1093/glycob/cwp041
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow All Versions of this Article:
19/7/735    most recent
cwp041v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Basappa,
Right arrow Articles by Sugahara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basappa,
Right arrow Articles by Sugahara, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Involvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells

Basappa1,6*, Sengottuvelan Murugan1,*, Kazuki N. Sugahara2,3, Chun Man Lee2,4, Gerdy B. ten Dam5, Toin H. van Kuppevelt5, Masayuki Miyasaka2, Shuhei Yamada1,{dagger} and Kazuyuki Sugahara1,{dagger}

1 Graduate School of Life Science, Hokkaido University, Sapporo, Japan
2 Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University, Graduate School of Medicine, Suita, Japan
3 Vascular Mapping Center, Burnham Institute for Medical Research UCSB, University of California, Santa Barbara, CA
4 Medical Center for Translational Research, Osaka University Hospital, Suita, Japan
5 Department of Biochemistry, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
6 Department of Chemistry, Bangalore University, Bangalore, India.


{dagger} To whom correspondence may be addressed: Tel.: 81-(11)-706–9055; Fax: 81-(11)-706–9055; E-mail: tjohej{at}sci.hokudai.ac.jp

{dagger} To whom correspondence may be addressed: Tel.: 81-(11)-706–9054; Fax: 81-(11)-706–9056; E-mail: k-sugar{at}sci.hokudai.ac.jp

Received on December 26, 2008; accepted on March 12, 2009

Cell surface heparan sulfate plays a critical role in regulating the metastatic behavior of tumor cells, whereas the role of chondroitin sulfate/dermatan sulfate (CS/DS) has been little understood in this context. Here, we characterized CS/DS chains from the murine osteosarcoma cell line LM8G7, which forms tumor nodules in liver. Structural analysis of the CS/DS chains showed a higher proportion of GlcUAβ1-3GalNAc(4,6-O-disulfate) (E-units) in LM8G7 (12%) than in its parental cell line LM8 (6%), which rarely forms tumors in the liver. Immunostaining with GD3G7, an antibody specific to E-units, confirmed the higher expression of the epitope in LM8G7 than LM8 cells. The tumor focal formation of LM8G7 cells to the liver in mice was effectively inhibited by the pre-administration of CS-E (rich in E-unit) or the pre-incubation of the antibody GD3G7 with the tumor cells. CS-E or GD3G7 inhibited the adhesion of LM8G7 cells to a laminin-coated plate in vitro. In addition, the invasive ability of LM8G7 cells in vitro was also reduced by the addition of CS-E or the antibody. Further, CS-E or the antibody inhibited the proliferation of LM8G7 cells dose-dependently. The binding of LM8G7 cells to VEGF in vitro was also significantly reduced by CS-E and GD3G7. Thus, the present study reveals the significance of highly sulfated CS/DS structures in the liver colonization of osteosarcoma cells and also provides a framework for the development of GAG-based anti-cancer molecules.

Key words: chondroitin sulfate / glycosaminoglycan / tumor / osteosarcoma / sulfation


* Equal Contribution


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.